<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34321318</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1946-6242</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>604</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>28</Day></PubDate></JournalIssue><Title>Science translational medicine</Title><ISOAbbreviation>Sci Transl Med</ISOAbbreviation></Journal><ArticleTitle>Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">eabe1923</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/scitranslmed.abe1923</ELocationID><Abstract><AbstractText>Alterations in the components [nucleoporins (Nups)] and function of the nuclear pore complex (NPC) have been implicated as contributors to the pathogenesis of genetic forms of neurodegeneration including <i>C9orf72</i> amyotrophic lateral sclerosis/frontotemporal dementia (ALS/FTD). We hypothesized that Nup alterations and the consequential loss of NPC function may lie upstream of TDP-43 dysfunction and mislocalization widely observed in ALS, FTD, and related neurodegenerative diseases. Here, we provide evidence that CHMP7, a critical mediator of NPC quality control, is increased in nuclei of <i>C9orf72</i> and sporadic ALS induced pluripotent stem cell (iPSC)-derived spinal neurons (iPSNs) and postmortem human motor cortex before the emergence of Nup alterations. Inhibiting the nuclear export of CHMP7 triggered Nup reduction and TDP-43 dysfunction and pathology in human neurons. Knockdown of CHMP7 alleviated disease-associated Nup alterations, deficits in Ran GTPase localization, defects in TDP-43-associated mRNA expression, and downstream glutamate-induced neuronal death. Thus, our data support a role for altered CHMP7-mediated Nup homeostasis as a prominent initiating pathological mechanism for familial and sporadic ALS and highlight the potential for CHMP7 as therapeutic target.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Coyne</LastName><ForeName>Alyssa N</ForeName><Initials>AN</Initials><Identifier Source="ORCID">0000-0002-3658-5325</Identifier><AffiliationInfo><Affiliation>Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. jrothstein@jhmi.edu acoyne3@jhmi.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baskerville</LastName><ForeName>Victoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaepfel</LastName><ForeName>Benjamin L</ForeName><Initials>BL</Initials><Identifier Source="ORCID">0000-0002-6822-7354</Identifier><AffiliationInfo><Affiliation>Biochemistry, Cellular, and Molecular Biology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dickson</LastName><ForeName>Dennis W</ForeName><Initials>DW</Initials><Identifier Source="ORCID">0000-0001-7189-7917</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rigo</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Ionis Pharmaceuticals, Carlsbad, CA 92010, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Frank</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-9887-6251</Identifier><AffiliationInfo><Affiliation>Ionis Pharmaceuticals, Carlsbad, CA 92010, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lusk</LastName><ForeName>C Patrick</ForeName><Initials>CP</Initials><Identifier Source="ORCID">0000-0003-4703-0533</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Yale School of Medicine, New Haven, CT 06520, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rothstein</LastName><ForeName>Jeffrey D</ForeName><Initials>JD</Initials><Identifier Source="ORCID">0000-0003-2001-8470</Identifier><AffiliationInfo><Affiliation>Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. jrothstein@jhmi.edu acoyne3@jhmi.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS094239</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG062171</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007445</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS122236</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K99 NS123242</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 NS084974</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 NS099114</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 NS091046</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Transl Med</MedlineTA><NlmUniqueID>101505086</NlmUniqueID><ISSNLinking>1946-6234</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C514910">CHMP7 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D056827">Endosomal Sorting Complexes Required for Transport</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C565957">Amyotrophic Lateral Sclerosis 2, Juvenile</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056827" MajorTopicYN="N">Endosomal Sorting Complexes Required for Transport</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022022" MajorTopicYN="N">Nuclear Pore</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>29</Day><Hour>5</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34321318</ArticleId><ArticleId IdType="mid">NIHMS1793866</ArticleId><ArticleId IdType="pmc">PMC9022198</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.abe1923</ArticleId><ArticleId IdType="pii">13/604/eabe1923</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW, Converging mechanisms in ALS and FTD: Disrupted RNA and protein homeostasis. Neuron 79, 416&#x2013;438 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH Jr., Cleveland DW, Decoding ALS: From genes to mechanism. Nature 539, 197&#x2013;206 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G, Gautier O, Tassoni-Tsuchida E, Ma XR, Gitler AD, ALS genetics: Gains, losses, and implications for future therapies. Neuron 108, 822&#x2013;842 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>Sances S, Bruijn LI, Chandran S, Eggan K, Ho R, Klim JR, Livesey MR, Lowry E, Macklis JD, Rushton D, Sadegh C, Sareen D, Wichterle H, Zhang S-C, Svendsen CN, Modeling ALS with motor neurons derived from human induced pluripotent stem cells. Nat. Neurosci 19, 542&#x2013;553 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5015775</ArticleId><ArticleId IdType="pubmed">27021939</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Hu D, Shang Y, Qi X, Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases. Biochim. Biophys. Acta Mol. Basis Dis 1866, 165431 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6751032</ArticleId><ArticleId IdType="pubmed">30898538</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly CJ, Zhang P-W, Pham JT, Haeusler AR, Mistry NA, Vidensky S, Daley EL, Poth EM, Hoover B, Fines DM, Maragakis N, Tienari PJ, Petrucelli L, Traynor BJ, Wang J, Rigo F, Bennett CF, Blackshaw S, Sattler R, Rothstein JD, RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80, 415&#x2013;428 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Chew J, Stankowski JN, Hayes LR, Zhang Y-J, Prudencio M, Carlomagno Y, Daughrity LM, Jansen-West K, Perkerson EA, O&#x2019;Raw A, Cook C, Pregent L, Belzil V, van Blitterswijk M, Tabassian LJ, Lee CW, Yue M, Tong J, Song Y, Castanedes-Casey M, Rousseau L, Phillips V, Dickson DW, Rademakers R, Fryer JD, Rush BK, Pedraza O, Caputo AM, Desaro P, Palmucci C, Robertson A, Heckman MG, Diehl NN, Wiggs E, Tierney M, Braun L, Farren J, Lacomis D, Ladha S, Fournier CN, McCluskey LF, Elman LB, Toledo JB, McBride JD, Tiloca C, Morelli C, Poletti B, Solca F, Prelle A, Wuu J, Jockel-Balsarotti J, Rigo F, Ambrose C, Datta A, Yang W, Raitcheva D, Antognetti G, McCampbell A, van Swieten JC, Miller BL, Boxer AL, Brown RH, Bowser R, Miller TM, Trojanowski JQ, Grossman M, Berry JD, Hu WT, Ratti A, Traynor BJ, Disney MD, Benatar M, Silani V, Glass JD, Floeter MK, Rothstein JD, Boylan KB, Petrucelli L, Poly(GP) proteins are a useful pharmacodynamic marker forC9ORF72-associated amyotrophic lateral sclerosis. Sci. Transl. Med 9, eaai7866 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576451</ArticleId><ArticleId IdType="pubmed">28356511</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne AN, Zaepfel BL, Hayes L, Fitchman B, Salzberg Y, Luo E-C, Bowen K, Trost H, Aigner S, Rigo F, Yeo GW, Harel A, Svendsen CN, Sareen D, Rothstein JD, G4C2 repeat RNA initiates a POM121-mediated reduction in specific nucleoporins in C9orf72 ALS/FTD. Neuron 107, 1124&#x2013;1140.e11 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8077944</ArticleId><ArticleId IdType="pubmed">32673563</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck M, Hurt E, The nuclear pore complex: Understanding its function through structural insight. Nat. Rev. Mol. Cell Biol 18, 73&#x2013;89 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27999437</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin DH, Hoelz A, The structure of the nuclear pore complex (an update). Annu. Rev. Biochem 88, 725&#x2013;783 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6588426</ArticleId><ArticleId IdType="pubmed">30883195</ArticleId></ArticleIdList></Reference><Reference><Citation>Raices M, D&#x2019;Angelo MA, Nuclear pore complex composition: A new regulator of tissue-specific and developmental functions. Nat. Rev. Mol. Cell Biol 13, 687&#x2013;699 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">23090414</ArticleId></ArticleIdList></Reference><Reference><Citation>Raices M, D&#x2019;Angelo MA, Nuclear pore complexes and regulation of gene expression. Curr. Opin. Cell Biol 46, 26&#x2013;32 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5505778</ArticleId><ArticleId IdType="pubmed">28088069</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster BM, Colombi P, Jager J, Lusk CP, Surveillance of nuclear pore complex assembly by ESCRT-III/Vps4. Cell 159, 388&#x2013;401 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4194032</ArticleId><ArticleId IdType="pubmed">25303532</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaller DJ, Allegretti M, Borah S, Ronchi P, Beck M, Lusk CP, An ESCRT-LEM protein surveillance system is poised to directly monitor the nuclear envelope and nuclear transport system. eLife 8, e45284 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6461442</ArticleId><ArticleId IdType="pubmed">30942170</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster BM, Thaller DJ, J&#xe4;ger J, Ochmann SE, Borah S, Lusk CP, Chm7 and Heh1 collaborate to link nuclear pore complex quality control with nuclear envelope sealing. EMBO J. 35, 2447&#x2013;2467 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5109239</ArticleId><ArticleId IdType="pubmed">27733427</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyama BH, Drigo RAE, Lev-Ram V, Ramachandra R, Deerinck TJ, Lechene C, Ellisman MH, Hetzer MW, Visualization of long-lived proteins reveals age mosaicism within nuclei of postmitotic cells. J. Cell Biol 218, 433&#x2013;444 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6363465</ArticleId><ArticleId IdType="pubmed">30552100</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CW, Wilfling F, Ronchi P, Allegretti M, Mosalaganti S, Jentsch S, Beck M, Pfander B, Selective autophagy degrades nuclear pore complexes. Nat. Cell Biol 22, 159&#x2013;166 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32029894</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomioka Y, Kotani T, Kirisako H, Oikawa Y, Kimura Y, Hirano H, Ohsumi Y, Nakatogawa H, TORC1 inactivation stimulates autophagy of nucleoporin and nuclear pore complexes. J. Cell Biol 219, e201910063 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337488</ArticleId><ArticleId IdType="pubmed">32453403</ArticleId></ArticleIdList></Reference><Reference><Citation>Lusk CP, Ader NR, CHMPions of repair: Emerging perspectives on sensing and repairing the nuclear envelope barrier. Curr. Opin. Cell Biol 64, 25&#x2013;33 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7371540</ArticleId><ArticleId IdType="pubmed">32105978</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W, Philips T, The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci 14, 248&#x2013;264 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglione M, Sigrist SJ, Seeing the forest tree by tree: Super-resolution light microscopy meets the neurosciences. Nat. Neurosci 16, 790&#x2013;797 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23799471</ArticleId></ArticleIdList></Reference><Reference><Citation>Schermelleh L, Carlton PM, Haase S, Shao L, Winoto L, Kner P, Burke B, Cardoso MC, Agard DA, Gustafsson MGL, Leonhardt H, Sedat JW, Subdiffraction multicolor imaging of the nuclear periphery with 3D structured illumination microscopy. Science 320, 1332&#x2013;1336 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916659</ArticleId><ArticleId IdType="pubmed">18535242</ArticleId></ArticleIdList></Reference><Reference><Citation>Clift D, McEwan WA, Labzin LI, Konieczny V, Mogessie B, James LC, Schuh M, A method for the acute and rapid degradation of endogenous proteins. Cell 171, 1692&#x2013;1706.e18 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5733393</ArticleId><ArticleId IdType="pubmed">29153837</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, Bogaert E, Van Damme P, Van Den Bosch L, Inside out: The role of nucleocytoplasmic transport in ALS and FTLD. Acta Neuropathol. 132, 159&#x2013;173 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4947127</ArticleId><ArticleId IdType="pubmed">27271576</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutten S, Dormann D, Nucleocytoplasmic transport defects in neurodegeneration-Cause or consequence? Semin. Cell Dev. Biol. 99, 151&#x2013;162 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31152789</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovicic A, Paul III JW, Gitler AD, Nuclear transport dysfunction: A common theme in amyotrophic lateral sclerosis and frontotemporal dementia. J. Neurochem 138 (Suppl 1), 134&#x2013;144 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27087014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Taylor JP, Lost in transportation: Nucleocytoplasmic transport defects in ALS and other neurodegenerative diseases. Neuron 96, 285&#x2013;297 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5678982</ArticleId><ArticleId IdType="pubmed">29024655</ArticleId></ArticleIdList></Reference><Reference><Citation>Vietri M, Schultz SW, Bellanger A, Jones CM, Petersen LI, Raiborg C, Skarpen E, Pedurupillay CRJ, Kjos I, Kip E, Timmer R, Jain A, Collas P, Knorr RL, Grellscheid SN, Kusumaatmaja H, Brech A, Micci F, Stenmark H, Campsteijn C, Unrestrained ESCRT-III drives micronuclear catastrophe and chromosome fragmentation. Nat. Cell Biol 22, 856&#x2013;867 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32601372</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu M, LaJoie D, Chen O-S, von Appen A, Ladinsky MS, Redd MJ, Nikolova L, Bjorkman PJ, Sundquist WI, Ullman KS, Frost A, LEM2 recruits CHMP7 for ESCRT-mediated nuclear envelope closure in fission yeast and human cells. Proc. Natl. Acad. Sci. U.S.A 114, E2166&#x2013;E2175 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5358359</ArticleId><ArticleId IdType="pubmed">28242692</ArticleId></ArticleIdList></Reference><Reference><Citation>Suk TR, Rousseaux MWC, The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol. Neurodegener 15, 45 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429473</ArticleId><ArticleId IdType="pubmed">32799899</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatsavayai SC, Yoon SJ, Gardner RC, Gendron TF, Vargas JNS, Trujillo A, Pribadi M, Phillips JJ, Gaus SE, Hixson JD, Garcia PA, Rabinovici GD, Coppola G, Geschwind DH, Petrucelli L, Miller BL, Seeley WW, Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia. Brain J. Neurol 139, 3202&#x2013;3216 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5790143</ArticleId><ArticleId IdType="pubmed">27797809</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J, Wang L, Huntley ML, Perry G, Wang X, Pathomechanisms of TDP-43 in neurodegeneration. J. Neurochem 146, 7&#x2013;20 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6110993</ArticleId><ArticleId IdType="pubmed">29486049</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne AN, Zaepfel BL, Zarnescu DC, Failure to deliver and translate-new insights into RNA dysregulation in ALS. Front. Cell. Neurosci 11, 243 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5562674</ArticleId><ArticleId IdType="pubmed">28860970</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z, L&#xf3;pez-Erauskin J, Baughn MW, Zhang O, Drenner K, Sun Y, Freyermuth F, Mahon MAM, Beccari MS, Artates JW, Ohkubo T, Rodriguez M, Lin N, Wu D, Bennett CF, Rigo F, Cruz SD, Ravits J, Lagier-Tourenne C, Cleveland DW, Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci 22, 180&#x2013;190 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Humphrey J, Pickles S, Brown AL, Hill SE, Kachergus JM, Shi J, Heckman MG, Spiegel MR, Cook C, Song Y, Yue M, Daughrity LM, Carlomagno Y, Jansen-West K, de Castro CF, DeTure M, Koga S, Wang YC, Sivakumar P, Bodo C, Candalija A, Talbot K, Selvaraj BT, Burr K, Chandran S, Newcombe J, Lashley T, Hubbard I, Catalano D, Kim D, Propp N, Fennessey S;NYGC ALS Consortium, Fagegaltier D, Phatnani H, Secrier M, Fisher EM, Oskarsson B, van Blitterswijk M, Rademakers R, Graff-Radford NR, Boeve BF, Knopman DS, Petersen RC, Josephs KA, Thompson EA, Raj T, Ward M, Dickson DW, Gendron TF, Fratta P, Petrucelli L, Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. J. Clin. Invest 130, 6080&#x2013;6092 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598060</ArticleId><ArticleId IdType="pubmed">32790644</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim JR, Williams LA, Limone F, Guerra San Juan I, Davis-Dusenbery BN, Mordes DA, Burberry A, Steinbaugh MJ, Gamage KK, Kirchner R, Moccia R, Cassel SH, Chen K, Wainger BJ, Woolf CJ, Eggan K, ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci 22, 167&#x2013;179 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>DeTure MA, Dickson DW, The neuropathological diagnosis of Alzheimer&#x2019;s disease. Mol. Neurodegener 14, 32 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6679484</ArticleId><ArticleId IdType="pubmed">31375134</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson VE, Stewart W, Trojanowski JQ, Smith DH, Acute and chronically increased immunoreactivity to phosphorylation-independent but not pathological TDP-43 after a single traumatic brain injury in humans. Acta Neuropathol 122, 715&#x2013;726 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3979333</ArticleId><ArticleId IdType="pubmed">22101322</ArticleId></ArticleIdList></Reference><Reference><Citation>Thammisetty SS, Pedragosa J, Weng YC, Calon F, Planas A, Kriz J, Age-related deregulation of TDP-43 after stroke enhances NF-&#x3ba;B-mediated inflammation and neuronal damage. J. Neuroinflammation 15, 312 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6230239</ArticleId><ArticleId IdType="pubmed">30413172</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVos SL, Miller TM, Antisense oligonucleotides: Treating neurodegeneration at the level of RNA. Neurotherapeutics 10, 486&#x2013;497 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3701770</ArticleId><ArticleId IdType="pubmed">23686823</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoch KM, Miller TM, Antisense oligonucleotides: Translation from mouse models to human neurodegenerative diseases. Neuron 94, 1056&#x2013;1070 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5821515</ArticleId><ArticleId IdType="pubmed">28641106</ArticleId></ArticleIdList></Reference><Reference><Citation>Melchior F, Ran GTPase cycle: One mechanism&#x2014;Two functions. Curr. Biol 11, R257&#x2013;R260 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11413013</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou CC, Zhang Y, Umoh ME, Vaughan SW, Lorenzini I, Liu F, Sayegh M, Donlin-Asp PG, Chen YH, Duong DM, Seyfried NT, Powers MA, Kukar T, Hales CM, Gearing M, Cairns NJ, Boylan KB, Dickson DW, Rademakers R, Zhang Y-J, Petrucelli L, Sattler R, Zarnescu DC, Glass JD, Rossoll W, TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci 21,228&#x2013;239 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Eftekharzadeh B, Daigle JG, Kapinos LE, Coyne A, Schiantarelli J, Carlomagno Y, Cook C, Miller SJ, Dujardin S, Amaral AS, Grima JC, Bennett RE, Tepper K, De Ture M, Vanderburg CR, Corjuc BT, De Vos SL, Gonzalez JA, Chew J, Vidensky S, Gage FH, Mertens J, Troncoso J, Mandelkow E, Salvatella X, Lim RYH, Petrucelli L, Wegmann S, Rothstein JD, Hyman BT, Tau protein disrupts nucleocytoplasmic transport in Alzheimer&#x2019;s disease. Neuron 99, 925&#x2013;940.e7 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6240334</ArticleId><ArticleId IdType="pubmed">30189209</ArticleId></ArticleIdList></Reference><Reference><Citation>Grima JC, Daigle JG, Arbez N, Cunningham KC, Zhang K, Ochaba J, Geater C, Morozko E, Stocksdale J, Glatzer JC, Pham JT, Ahmed I, Peng Q, Wadhwa H, Pletnikova O, Troncoso JC, Duan W, Snyder SH, Ranum LPW, Thompson LM, Lloyd TE, Ross CA, Rothstein JD, Mutant huntingtin disrupts the nuclear pore complex. Neuron 94, 93&#x2013;107.e6 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5595097</ArticleId><ArticleId IdType="pubmed">28384479</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Donnelly CJ, Haeusler AR, Grima JC, Machamer JB, Steinwald P, Daley EL, Miller SJ, Cunningham KM, Vidensky S, Gupta S, Thomas MA, Hong I, Chiu SL, Huganir RL, Ostrow LW, Matunis MJ, Wang J, Sattler R, Lloyd TE, Rothstein JD, The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525, 56&#x2013;61 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J, Cook C, Gendron TF, Jansen-West K, del Rosso G, Daughrity LM, Castanedes-Casey M, Kurti A, Stankowski JN, Disney MD, Rothstein JD, Dickson DW, Fryer JD, Zhang Y-J, Petrucelli L, Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy. Mol. Neurodegener 14, 9 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6377782</ArticleId><ArticleId IdType="pubmed">30767771</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Gendron TF, Ebbert MTW, O&#x2019;Raw AD, Yue M, Jansen-West K, Zhang X, Prudencio M, Chew J, Cook CN, Daughrity LM, Tong J, Song Y, Pickles SR, Castanedes-Casey M, Kurti A, Rademakers R, Oskarsson B, Dickson DW, Hu W, Gitler AD, Fryer JD, Petrucelli L, Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis. Nat. Med 24, 1136&#x2013;1142 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6520050</ArticleId><ArticleId IdType="pubmed">29942091</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Gendron TF, Grima JC, Sasaguri H, Jansen-West K, Xu Y-F, Katzman RB, Gass J, Murray ME, Shinohara M, Lin W-L, Garrett A, Stankowski JN, Daughrity L, Tong J, Perkerson EA, Yue M, Chew J, Castanedes-Casey M, Kurti A, Wang ZS, Liesinger AM, Baker JD, Jiang J, Lagier-Tourenne C, Edbauer D, Cleveland DW, Rademakers R, Boylan KB, Bu G, Link CD, Dickey CA, Rothstein JD, Dickson DW, Fryer JD, Petrucelli L, C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nat. Neurosci 19, 668&#x2013;677 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5138863</ArticleId><ArticleId IdType="pubmed">26998601</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y-J, Guo L, Gonzales PK, Gendron TF, Wu Y, Jansen-West K, O&#x2019;Raw AD, Pickles SR, Prudencio M, Carlomagno Y, Gachechiladze MA, Ludwig C, Tian R, Chew J, De Ture M, Lin W-L, Tong J, Daughrity LM, Yue M, Song Y, Andersen JW, Castanedes-Casey M, Kurti A, Datta A, Antognetti G, Campbell AM, Rademakers R, Oskarsson B, Dickson DW, Kampmann M, Ward ME, Fryer JD, Link CD, Shorter J, Petrucelli L, Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity. Science 363, eaav2606 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6524780</ArticleId><ArticleId IdType="pubmed">30765536</ArticleId></ArticleIdList></Reference><Reference><Citation>Thevathasan JV, Kahnwald M, Cie&#x15b;li&#x144;ski K, Hoess P, Peneti SK, Reitberger M, Heid D, Kasuba KC, Hoerner SJ, Li Y, Wu Y-L, Mund M, Matti U, Pereira PM, Henriques R, Nijmeijer B, Kueblbeck M, Sabinina VJ, Ellenberg J, Ries J, Nuclear pores as versatile reference standards for quantitative superresolution microscopy. Nat. Methods 16, 1045&#x2013;1053 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6768092</ArticleId><ArticleId IdType="pubmed">31562488</ArticleId></ArticleIdList></Reference><Reference><Citation>McCullough J, Frost A, Sundquist WI, Structures, functions, and dynamics of ESCRT-III/Vps4 membrane remodeling and fission complexes. Annu. Rev. Cell Dev. Biol 34, 85&#x2013;109 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6241870</ArticleId><ArticleId IdType="pubmed">30095293</ArticleId></ArticleIdList></Reference><Reference><Citation>Vietri M, Radulovic M, Stenmark H, The many functions of ESCRTs. Nat. Rev. Mol. Cell Biol 21,25&#x2013;42 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31705132</ArticleId></ArticleIdList></Reference><Reference><Citation>Skibinski G, Parkinson NJ, Brown JM, Chakrabarti L, Lloyd SL, Hummerich H, Nielsen JE, Hodges JR, Spillantini MG, Thusgaard T, Brandner S, Brun A, Rossor MN, Gade A, Johannsen P, S&#xf8;rensen SA, Gydesen S, Fisher EM-C, Collinge J, Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat. Genet 37, 806&#x2013;808 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16041373</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang XL, Tan MS, Tan L, Yu JT, The role of TDP-43 in Alzheimer&#x2019;s disease. Mol. Neurobiol 53, 3349&#x2013;3359 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26081142</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, Mc Cluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM-Y, Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130&#x2013;133 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Whitwell JL, Weigand SD, Murray ME, Tosakulwong N, Liesinger AM, Petrucelli L, Senjem ML, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Jack CR Jr., Parisi JE, Petersen RC, Dickson DW, TDP-43 is a key player in the clinical features associated with Alzheimer&#x2019;s disease. Acta Neuropathol 127, 811&#x2013;824 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4172544</ArticleId><ArticleId IdType="pubmed">24659241</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson JL, Lee EB, Xie SX, Rennert L, Suh E-R, Bredenberg C, Caswell C, van Deerlin VM, Yan N, Yousef A, Hurtig HI, Siderowf A, Grossman M, McMillan CT, Miller B, Duda JE, Irwin DJ, Wolk D, Elman L, McCluskey L, Chen-Plotkin A, Weintraub D, Arnold SE, Brettschneider J, Lee VM-Y, Trojanowski JQ, Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain J. Neurol 141,2181&#x2013;2193 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6022546</ArticleId><ArticleId IdType="pubmed">29878075</ArticleId></ArticleIdList></Reference><Reference><Citation>Vossel KA, Bien-Ly N, Bernardo A, Rascovsky K, Karydas A, Rabinovici GD, Sidhu M, Huang EJ, Miller BL, Huang Y, Seeley WW, ApoE and TDP-43 neuropathology in two siblings with familial FTLD-motor neuron disease. Neurocase 19, 295&#x2013;301 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3655113</ArticleId><ArticleId IdType="pubmed">22512241</ArticleId></ArticleIdList></Reference><Reference><Citation>Wennberg AM, Tosakulwong N, Lesnick TG, Murray ME, Whitwell JL, Liesinger AM, Petrucelli L, Boeve BF, Parisi JE, Knopman DS, Petersen RC, Dickson DW, Josephs KA, Association of apolipoprotein E &#x3b5;4 with transactive response DNA-binding protein 43. JAMA Neurol. 75, 1347&#x2013;1354 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6248121</ArticleId><ArticleId IdType="pubmed">30422173</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang HS, Yu L, White CC, Chibnik LB, Chhatwal JP, Sperling RA, Bennett DA, Schneider JA, de Jager PL, Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE &#x3b5;4 haplotype status: A community-based cohort study. Lancet Neurol. 17, 773&#x2013;781 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6154505</ArticleId><ArticleId IdType="pubmed">30093249</ArticleId></ArticleIdList></Reference><Reference><Citation>Sennepin AD, Charpentier S, Normand T, Sarr&#xe9; C, Legrand A, Mollet LM, Multiple reprobing of Western blots after inactivation of peroxidase activity by its substrate, hydrogen peroxide. Anal. Biochem 393, 129&#x2013;131 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19523435</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>